Robins Jason Shand bought OCUL
January 20, 2026 · Form 4 insider transaction
Robins Jason Shand bought 33,000 shares of Ocular Therapeutix, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
33,000
Price
$0.00
Total value
N/A
InsiderRobins Jason Shand
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 20, 2026
Filing dateJanuary 22, 2026
Shares owned after33,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.